Literature DB >> 14685006

Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy.

Georgios Karanikas1, Matthias Schütz, Monica Szabo, Alexander Becherer, Karoline Wiesner, Robert Dudczak, Kurt Kletter.   

Abstract

AIM: To investigate the possible changes in the renal tubular function in severe short-term hypothyroidism using (99m)Tc-MAG(3) renography.
METHODS: 27 consecutive thyroidectomized patients (7 males and 20 females) aged 19-79 (mean 53) years were included in the present study. (99m)Tc-MAG(3) renography was performed in all patients before and after thyroid hormone replacement therapy. In addition, (51)Cr-EDTA clearance and serum creatinine concentrations were determined.
RESULTS: The serum creatinine concentrations were significantly increased in hypothyroidism as compared with the concentrations after thyroxine substitution (1.30 +/- 0.44 vs. 1.04 +/- 0.32 mg/dl, p < 0.05). According to the (51)Cr-EDTA clearance, the glomerular filtration rate was significantly lower in hypothyroidism than after treatment (61 +/- 18 vs. 75 +/- 23 ml/min). In contrast, we did not find any significant change in the renographic parameters for (99m)Tc-MAG(3) before and after treatment (total excreted activity 20 min after administration 51 +/- 12 vs. 54 +/- 14%; T(max) left:right 4.2 +/- 1.77 : 3.91 +/- 1.06 min vs. 4.1 +/- 1.66 : 4.4 +/- 1.96 min).
CONCLUSIONS: We did not find any influence of thyroid hormones on the outcome of (99m )Tc-MAG(3) renography. As (99m)Tc-MAG(3) reflects the tubular function, it seems that the renal hemodynamic changes in severe hypothyroidism mainly affect the glomerular function. In general, the glomerular filtration rate reduction seems to be reversible after hormone substitution therapy; however, care has to be taken in patients with renal insufficiency. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14685006     DOI: 10.1159/000075628

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  26 in total

Review 1.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

2.  Impaired estimated glomerular filtration rate associated with hypothyroidism. Does it really mean an acute renal failure?

Authors:  Dieter Brueckner; Maike Brueckner
Journal:  BMJ Case Rep       Date:  2009-04-03

3.  The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects.

Authors:  Da Young Lee; Jae Hwan Jee; Ji Eun Jun; Tae Hyuk Kim; Sang-Man Jin; Kyu Yeon Hur; Sun Wook Kim; Jae Hoon Chung; Moon-Kyu Lee; Jae Hyeon Kim
Journal:  Endocrine       Date:  2016-10-05       Impact factor: 3.633

4.  Age and the thyrotropin response to hypothyroxinemia.

Authors:  Rebecca Over; Sonia Mannan; Hala Nsouli-Maktabi; Kenneth D Burman; Jacqueline Jonklaas
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

Review 5.  Thyroid disease in end-stage renal disease.

Authors:  Connie M Rhee
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-11       Impact factor: 2.894

6.  Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of renal function in chronic kidney disease patients.

Authors:  Yuji Hataya; Shuta Igarashi; Takafumi Yamashita; Yasato Komatsu
Journal:  Clin Exp Nephrol       Date:  2012-11-17       Impact factor: 2.801

7.  Influence of thyroid function on glomerular filtration rate and other estimates of kidney function in two pediatric patients.

Authors:  Osamu Uemura; Naoyuki Iwata; Takuhito Nagai; Satoshi Yamakawa; Satoshi Hibino; Masaki Yamamoto; Masaru Nakano; Kazuki Tanaka
Journal:  CEN Case Rep       Date:  2018-02-28

8.  Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin.

Authors:  Yoon Young Cho; Soo Kyoung Kim; Jung Hwa Jung; Jong Ryeal Hahm; Tae Hyuk Kim; Jae Hoon Chung; Sun Wook Kim
Journal:  Endocrine       Date:  2018-11-23       Impact factor: 3.633

Review 9.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

10.  Thyroid function and cardiovascular events in chronic kidney disease patients.

Authors:  Baris Afsar; Mahmut Ilker Yilmaz; Dimitrie Siriopol; Hilmi Umut Unal; Mutlu Saglam; Murat Karaman; Mustafa Gezer; Alper Sonmez; Tayfun Eyileten; Ibrahim Aydin; Salih Hamcan; Yusuf Oguz; Adrian Covic; Mehmet Kanbay
Journal:  J Nephrol       Date:  2016-04-02       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.